ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Mc-Val-Cit-PAB-Cl
C28H39ClN6O6
591.1 g/mol
Pharmaceutical Intermediate

Mc-Val-Cit-PAB-Cl

CAS1639351-92-0
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Mc-Val-Cit-PAB-Cl is a chemical compound used as a linker intermediate in the manufacturing of antibody-drug conjugates. Its structure includes a maleimide group for conjugation, a valine-citrulline dipeptide, and a chloromethyl-bearing aniline unit.

Antibody-drug conjugate linker intermediatePharmaceutical intermediate for targeted drug delivery research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Mc-Val-Cit-PAB-Cl?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.88

N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide

CAS159857-80-4

pharmaceutical intermediate

ReferenceSame Category

2-((2,2-Diphenylvinyl)oxy)-4,6-dimethylpyrimidine

CAS1639429-81-4

pharmaceutical intermediate

ReferenceSame Category

MC-Val-Ala-PAB-PNP

CAS1639939-40-4

pharmaceutical intermediate

ReferenceSame Category

2,3,3-Trimethylindolenine

CAS1640-39-7

pharmaceutical intermediate

ReferenceSame Category

Ethyl 4-acetoxy-1-benzyl-2-methyl-1H-benzo[d]imidazole-6-carboxylate

CAS1640981-11-8

pharmaceutical intermediate

Referencesame scaffold

Mc-Val-Ala-PAB

CAS1870916-87-2

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-(chloromethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-(2,5-dioxopyrrol-1-yl)hexanamide

InChIKey

TUMQZNBKSWFFAZ-OFVILXPXSA-N

SMILES

CC(C)[C@@H](C(=O)N[C@@H](CCCNC(=O)N)C(=O)NC1=CC=C(C=C1)CCl)NC(=O)CCCCCN2C(=O)C=CC2=O

Synonyms (5)
  • Mc-Val-Cit-PAB-Cl

Sourcing Mc-Val-Cit-PAB-Cl?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→